Asymmetry Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $2.98M | Sell |
369,134
-105,234
| -22% | -$850K | 1.58% | 20 |
|
|
2021
Q3 | $4.65M | Buy |
474,368
+74,592
| +19% | +$731K | 2.79% | 18 |
|
|
2021
Q2 | $2.69M | Sell |
399,776
-312,595
| -44% | -$2.1M | 1.85% | 20 |
|
|
2021
Q1 | $6.44M | Sell |
712,371
-243,485
| -25% | -$2.2M | 3.33% | 15 |
|
|
2020
Q4 | $6.39M | Buy |
955,856
+435,026
| +84% | +$2.91M | 2.91% | 14 |
|
|
2020
Q3 | $2.63M | Sell |
520,830
-12,802
| -2% | -$64.5K | 1.69% | 23 |
|
|
2020
Q2 | $4.31M | Buy |
+533,632
| New | +$4.31M | 3.3% | 12 |
|